We are supported by a strong consortium of investors, having secured significant additional backing in our recent Series B funding round. Our investors include:

TVM Life Science Innovation I.L.P.

TVM Life Science Innovation I.L.P. has been delivering international investment for over 30 years, and provides venture capital to the international pharmaceutical, biopharmaceutical, and medical technology industries.

Evotec SE

Formalising its Discovery and Development Services in 2002, Evotec SE creates partnerships to further research in multiple health fields, including cancer and infectious diseases. leon and Evotec’s strategic partnership will maximise the effectiveness of clinical and commercial nano-medicine development.

Albany Private Equity Holdings Pty Ltd

Part of The Pacific Group of Companies, Albany Private Equity Holdings is an Australian private equity investment firm with a focus on transformational healthcare and investments in medical technology, biotech, and pharmaceuticals.

Eckenstein-Geigy-Stiftung

Eckenstein-Geigy-Stiftung is a Swiss family investment office. Established in 2007 on philanthropic principles, it is focused on building a good future for everybody, including improved medical care for greater quality of life globally.

CD-Venture GmbH

CD-Venture is a German venture capital firm with two decades of experience specialising in investments in the life sciences sector.

BayBG

BayBG is a Munich-based equity investor with more than 45 years’ experience, offering venture capital investment for technology-driven companies.